Evidence map›Paper›PMID 38247899›Full record

ArticleBioengineering (Basel, Switzerland)2023

A Genetic Circuit Design for Targeted Viral RNA Degradation.

Adebayo J Bello, Abdulgafar Popoola, Joy Okpuzor, Adaoha E Ihekwaba-Ndibe, Femi J Olorunniji

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Adebayo J BelloSchool of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.ORCID 0000-0002-6731-2047
Abdulgafar PopoolaSchool of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.
Joy OkpuzorDepartment of Cell Biology & Genetics, University of Lagos, Akoka, Lagos 101017, Lagos State, Nigeria.
Adaoha E Ihekwaba-NdibeSchool of Life Sciences, Alison Gingell Building, Coventry University, Coventry CV1 2DS, UK.
Femi J OlorunnijiSchool of Pharmacy & Biomolecular Sciences, Liverpool John Moores University, Liverpool L3 3AF, UK.ORCID 0000-0001-9389-2981
Liverpool John Moores University · GBCoventry University · GBRedeemer's University · NGUniversity of Lagos · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in synthetic biology have led to the design of biological parts that can be assembled in different ways to perform specific functions. For example, genetic circuits can be designed to execute specific therapeutic functions, including gene therapy or targeted detection and the destruction of invading viruses. Viral infections are difficult to manage through drug treatment. Due to their high mutation rates and their ability to hijack the host's ribosomes to make viral proteins, very few therapeutic options are available. One approach to addressing this problem is to disrupt the process of converting viral RNA into proteins, thereby disrupting the mechanism for assembling new viral particles that could infect other cells. This can be done by ensuring precise control over the abundance of viral RNA (vRNA) inside host cells by designing biological circuits to target vRNA for degradation. RNA-binding proteins (RBPs) have become important biological devices in regulating RNA processing. Incorporating naturally upregulated RBPs into a gene circuit could be advantageous because such a circuit could mimic the natural pathway for RNA degradation. This review highlights the process of viral RNA degradation and different approaches to designing genetic circuits. We also provide a customizable template for designing genetic circuits that utilize RBPs as transcription activators for viral RNA degradation, with the overall goal of taking advantage of the natural functions of RBPs in host cells to activate targeted viral RNA degradation.

Indexed as

genetic circuitRNA-binding proteinRNA degradationRNA virussynthetic biology

Identifiers

PMID38247899
PMCPMC10813695
OpenAlexW4390196141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.